1. **Cardiac troponins (Troponin I and Troponin T)** are the
gold-standard biomarkers for diagnosing acute myocardial infarction because
they are highly specific to cardiac muscle.
2. Troponin levels begin to rise **3–4 hours** after
myocardial injury and can remain elevated for **7–10 days**, making them useful
for both early and late detection.
3. **High-sensitivity troponin (hs-cTn)** assays can detect small amounts of the protein, allowing heart attacks to be ruled out or
confirmed much earlier.
4. **Creatine kinase-MB (CK-MB)** was traditionally used to
detect myocardial infarction and is especially helpful for identifying
**re-infarction**, since it returns to normal within 48–72 hours.
5. **Myoglobin** is one of the earliest markers to rise
(within 1–3 hours), but its lack of cardiac specificity limits its diagnostic
use.
6. **B-type natriuretic peptide (BNP)** and **NT-proBNP**
are key markers of **heart failure**, elevated when the ventricles are
stretched or under pressure.
7. **Lactate dehydrogenase (LDH)** and **AST (SGOT)** are
older, less specific markers that may remain elevated for a longer period after
myocardial damage.
8. Cardiac markers are most powerful when interpreted
**alongside symptoms, ECG findings, and imaging**, rather than relied upon
alone.

0 Comments